000

KOMIPHARM

No trades
See on Supercharts
Market capitalization
‪294.58 B‬KRW
‪−3.98 B‬KRW
‪42.65 B‬KRW
‪41.55 M‬
Beta (1Y)
0.18

About KOMIPHARM

Headquarters
Siheung-si
Employees (FY)
153
Founded
1972
ISIN
KR7041960006
FIGI
BBG000BMB381
Komipharm International Co., Ltd. engages in the development and manufacturing of natural food additives, veterinary vaccines and pharmaceuticals. It operates through Animal Health and Pharmaceuticals divisions. The Animal Health division manufactures veterinary products such as vaccines, antibiotics, antibacterial, nutrition, metabolic, immune boosters, digestive enzymes, expectorant, hormone, skin disease, anesthetic, antipyretic-analgesics and organic acid for being used to livestock, aqua and pet animals. The Pharmaceutical division develops pharmaceutical products such as anticancer drug and cancer pain-relieving agent under KOMINOX and PANAPHIX projects. The company was founded on September 21, 1972 and is headquartered in Siheung-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 041960 is 4145 KRW — it has decreased by 0.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KOMIPHARM stocks are traded under the ticker 041960.
041960 stock is 2.42% volatile and has beta coefficient of 0.18. Check out the list of the most volatile stocks — is KOMIPHARM there?
Yes, you can track KOMIPHARM financials in yearly and quarterly reports right on TradingView.
041960 stock has risen by 1.84% compared to the previous week, the month change is a 2.36% fall, over the last year KOMIPHARM has showed a 39.17% decrease.
041960 net income for the last quarter is ‪−1.01 B‬ KRW, while the quarter before that showed ‪−1.41 B‬ KRW of net income which accounts for 28.40% change. Track more KOMIPHARM financial stats to get the full picture.
Today KOMIPHARM has the market capitalization of ‪293.24 B‬, it has increased by 1.45% over the last week.
No, 041960 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 041960 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KOMIPHARM stock right from TradingView charts — choose your broker and connect to your account.
041960 reached its all-time high on Sep 9, 2016 with the price of 47510 KRW, and its all-time low was 250 KRW and was reached on Jun 28, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 153.00 employees. See our rating of the largest employees — is KOMIPHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KOMIPHARM technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KOMIPHARM stock shows the sell signal. See more of KOMIPHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KOMIPHARM EBITDA is ‪−2.87 B‬ KRW, and current EBITDA margin is −6.43%. See more stats in KOMIPHARM financial statements.